Indivumed Services
Scientist
on
December 3, 2024
This installment of Supplier Spotlight® highlights Indivumed Services, your partner for biomarker discovery and drug and CDx development to realize personalized oncology. Their services are available on the Scientist.com marketplace.
1. What is your company’s mission?
Indivumed Services, a Crown Bioscience Company, is a global contract research organization (CRO) dedicated to accelerating precision oncology by providing high-quality biospecimens, comprehensive clinical data and state-of- the art research services. Our mission is to support and enhance cancer research, enabling the scientific community to gain deeper insights and develop more effective, personalized treatments for cancer patients.
We offer an industry-leading oncology biobank as well as a range of service platforms designed to advance oncology and immuno-oncology drug discovery and development. Our unique biobank of clinical specimens, unparalleled in quality and associated clinical history, empowers our customers to deliver exceptional cancer care to patients worldwide.
2. What products and services do you offer?
Indivumed Services offers a range of products and services designed to support cancer research and precision oncology, including:
- A unique biobank of clinical specimens, unparalleled in quality and associated clinical history
- Our own global clinical network with strict SOPs controlling the quality of our biospecimens
- State-of-the-art lab services like multiplex fluorescent IHC assay development, spatial transcriptomics as a 10x Genomics Certified Service Provider and biomarker analysis
- A dedicated online platform for customers to self-select biospecimens and request a quote
- Expert consulting services.
3. What problems do you solve?
At Indivumed Services, we emphasize a controlled and standardized approach to sample collection. Our globally standardized, SOP-driven process guarantees the highest quality samples for your research needs. Our ability to combine over 300 patient data points with tumor tissue samples makes our biobank unique and an invaluable resource for every researcher. With over 20 years of experience, we are dedicated to minimizing cold ischemia times (~ 10 minutes) and ensuring consistent, high-quality tissue sample preparation.
In addition to this surgical biobank, we have a continuously expanding oncology practice network to establish a unique longitudinal cell-free plasma biobank. This allows the isolation of circulating tumor DNA (ctDNA) from pre- and post-treatment plasma samples.
We support our customers working in the oncology field to deliver therapies and diagnostics faster to their patients by providing tailored solutions for their biospecimen and/or biomarker assay needs.
4. What are the most innovative tools and technologies that you offer?
Equipped with state-of-the-art laboratories, our services extend from basic processing to complex analysis, employing cutting-edge technology for precise results.
We offer both chromogenic and fluorescent multiplex immunohistochemistry (fmIHC), capable of visualizing the co-expression of up to twelve markers on a single tissue section. As a 10x Genomics Certified Service Provider, we offer spatial gene expression solutions for a comprehensive understanding of the tissue microenvironment.
We also specialize in the isolation and characterization of cell populations, including tumor infiltrating lymphocytes (TILs) and peripheral blood mononuclear cells (PBMCs). Our services are designed to be combined and tailored to fit the specific requirements of each project, providing versatile and powerful tools for oncology research.
5. What are your competitive advantages?
We offer several competitive advantages:
- Our high-quality biospecimens are collected under rigorous and standardized conditions. This ensures consistency and reliability, which are crucial for reproducible research outcomes.
- In addition, we adhere to strict ethical standards and regulatory requirements, ensuring that all biospecimen collection and data usage comply with legal and ethical guidelines.
- Further, we utilize state-of-the-art technologies in genomics, proteomics and transcriptomics, offering advanced analytical services that cater to the cutting-edge needs of cancer research.
- We have CAP Accreditation and ISO 15189 Standard for our Quality Medical Laboratory Services in our facility in Hamburg, Germany.
6. Who are your clients?
We partner with pharma, biotech and IVD leaders for biomarker discovery and drug and CDx development to realize personalized oncology.
7. What new products and services are you developing?
We are constantly developing our in-house technologies further, for example, introduction of the high-definition slides for spatial transcriptomics or investing in the “protein simple” technology. Furthermore, we are enhancing our clinical network to accommodate as many customers’ needs as possible, like introducing Streck-plasma collections in addition to EDTA plasma.
8. Where are your laboratories and offices located?
Indivumed Services is headquartered in Hamburg, Germany with an additional facility in Frederick, Maryland, USA.
In April 2023, Indivumed Services was acquired by Crown Bioscience, a JSR Life Sciences company, ensuring client access to the latest clinically relevant translational models across their ex vivo patient tissue (EVPT), tumor organoid and patient-derived xenograft (PDX) model collections.